Skin in systemic disease
Turner, T.W.
Australian Family Physician 5(7): 890
1976
ISSN/ISBN: 0300-8495 PMID: 826242 Document Number: 97584
Document emailed within 1 workday
Related Documents
Furst, D.E.; Clements, P.J.; Steen, V.D.; Medsger, T.A.; Masi, A.T.; D'Angelo, W.A.; Lachenbruch, P.A.; Grau, R.G.; Seibold, J.R. 1998: The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis Journal of Rheumatology 25(1): 84-88Arnaudova, P.; Rashkov, R.; Tsanev, R. 1993: Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis Journal of Rheumatology 20(8): 1445-1446
Malcić, I.; Buljević, A.D.; Vucinić, D.; Carin, R. 1996: Polyarteritis nodosa--cutaneous or systemic form? Possible role of bacterial superantigens in the onset of systemic disease Reumatizam 43(1): 16-24
Vogel, C.A.; Balkrishnan, R.; Fleischer, A.B.; Cayce, K.A.; Feldman, S.R. 2004: Over-the-counter topical skin products--a common component of skin disease management Cutis 74(1): 55-67
Nguyen, G.; Torres, A. 2012: Systemic antioxidants and skin health Journal of Drugs in Dermatology: Jdd 11(9): E1-E4
Harvey, N.T.; Chan, J.; Wood, B.A. 2017: Skin biopsy in the diagnosis of neoplastic skin disease Australian Family Physician 46(5): 289-294
Omura, E.F. 1977: Skin reaction to systemic 5-FU-a therapeutic bonus New England Journal of Medicine 297(17): 946
Miki, Y. 1975: Skin conditions and their systemic background. 12. Ulcer Nihon Rinsho. Japanese Journal of Clinical Medicine 33(12): 3439-3444
Byekova, Y.; Hughey, L.; Elewski, B. 2011: Systemic drugs in patients with skin diseases Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 146(5): 397-424
Kockaert, M.; Neumann, M. 2003: Systemic and topical drugs for aging skin Journal of Drugs in Dermatology: Jdd 2(4): 435-441
Alsufyani, K.A.; Ortiz-Alvarez, O.; Cabral, D.A.; Tucker, L.B.; Petty, R.E.; Nadel, H.; Malleson, P.N. 2005: Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise Journal of Rheumatology 32(4): 729-733
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Levis, W.; Martiniuk, F. 2013: Molecular skin research can impact systemic cancers Journal of Drugs in Dermatology: Jdd 12(5): 510
Kozlovskaia, L.V.; Tareeva, I.E.; Tuganbekova, S.K.; Ianushkevich, T.N. 1988: Le cells in the "skin window" in patients with systemic lupus erythematosus Terapevticheskii Arkhiv 60(7): 88-90
Klotz, S.D.; Sweeney, M.J.; Dienst, S.; Klotz, L.R.; Moeller, R.K.; Rosenberg, S. 1982: Systemic anaphylaxis immediately following delayed hypersensitivity skin tests Annals of Allergy 49(3): 142-145
Uvarova, N.N. 1985: Clinical characteristics of the skin lesion in systemic scleroderma in children Pediatriia 8: 54-56
Sysa-Jedrzejowska, A.; Lutowiecka-Wranicz, A. 1977: Immunopathological studies of the skin from different areas in patients with systemic lupus erythematosus Przeglad Dermatologiczny 64(5): 543-547
Lutowiecka-Wranicz, A.; Sysa-Jedrzejowska, A.; Krykowski, E.; Pluzańska, A.; Dmochowska, M. 1977: Diagnostic value of immunopathological examinations of unchanged skin in systemic lupus erythematosus Przeglad Dermatologiczny 64(4): 409-414
Krámer, M.; Horváth, A.; Vajda, T.; Ablonczy, E.; Király, K. 1979: Histological and immunohistological studies of urticariform skin manifestations in systemic lupus erythematosus Orvosi Hetilap 120(29): 1737-1739
Marquez, C.; Bair, S.M.; Smithberger, E.; Cherpelis, B.S.; Glass, L.Frank. 2010: Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients Journal of Drugs in Dermatology: Jdd 9(7): 753-758